Edwards Lifesciences Corp/ US28176E1082 /
| 02.05.2024 18:13:16 | Diff. +0,35 | Volumen | Geld18:13:29 | Brief18:13:29 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 84,65USD | +0,42% | 518.116 Umsatz: 30,47 Mio. |
84,63Geld Vol: 200 | 84,67Brief Vol: 100 | 51,03 Mrd.USD | - | 36,66 |
Aktiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.060,3000 | 1.395,2000 | 1.546,6000 | 1.632,8000 | 1.749,4000 | ||||||
| Immaterielle Vermögensgegenstände | 336,5000 | 331,4000 | 323,6000 | 285,2000 | 428,4000 | ||||||
| Finanzanlagen | 585,5000 | 801,6000 | 1.834,2000 | 1.239 | 583,9000 | ||||||
| Anlagevermögen | 3.504,1000 | 4.146,1000 | 5.321,9000 | 5.196,7000 | 5.327,5000 | ||||||
| Vorräte | 640,9000 | 802,3000 | 726,7000 | 875,5000 | 1.168,2000 | ||||||
| Forderungen | 543,6000 | 514,6000 | 582,2000 | 643 | 775,1000 | ||||||
| Liquide Mitteln | 1.179,1000 | 1.183,2000 | 862,8000 | 769 | 1.144 | ||||||
| Umlaufvermögen | 2.984 | 3.091 | 3.180,7000 | 3.095,8000 | 4.035,7000 | ||||||
| Aktiva, gesamt | 6.488,1000 | 7.237,1000 | 8.502,6000 | 8.292,5000 | 9.363,2000 | ||||||
Passiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 180,4000 | 196,5000 | 204,5000 | 201,9000 | 201,4000 | ||||||
| Langfristige Schulden | 594,4000 | 595 | 595,7000 | 596,3000 | 597 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 696,5000 | 670,2000 | 802,3000 | - | - | ||||||
| Verbindlichkeiten | 2.339,8000 | 2.662,8000 | 2.666,7000 | 2.485,8000 | 2.643,8000 | ||||||
| Gezeichnetes Kapital | 654,3000 | 636,4000 | 642 | 646,3000 | 650,5000 | ||||||
| Eigenkapital | 4.148,3000 | 4.574,3000 | 5.835,9000 | 5.806,7000 | 6.719,4000 | ||||||
| Minderheitenanteile | - | - | - | - | 69,4000 | ||||||
| Passiva, gesamt | 6.488,1000 | 7.237,1000 | 8.502,6000 | 8.292,5000 | 9.363,2000 | ||||||
Gewinn- und Verlustrechnung
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 4.348 | 4.386,3000 | 5.232,5000 | 5.382,4000 | 6.004,8000 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | - | ||||||
| Betriebsergebnis | 1.146,8000 | 897,6000 | 1.690,3000 | 1.748,5000 | 1.534,1000 | ||||||
| Zinsergebnis | -11,5000 | -7,6000 | 1 | -16,3000 | -49,6000 | ||||||
| Ergebnis vor Steuern | 1.166,5000 | 916,7000 | 1.702 | 1.767,4000 | 1.598,1000 | ||||||
| Ertragsteuern | 119,6000 | 93,3000 | 198,9000 | 245,5000 | 198,7000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | - | - | - | - | -3 | ||||||
| Konzernjahresüberschuss | 1.046,9000 | 823,4000 | 1.503,1000 | 1.521,9000 | 1.402,4000 | ||||||
Pro Aktie
Cash Flow
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 1.179,4000 | 1.054,3000 | 1.732,1000 | 1.218,2000 | 895,8000 | ||||||
| Cash Flow aus Investitionstätigkeit | -595,8000 | -531,1000 | -1.722,5000 | 252,3000 | 173,8000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -115,6000 | -486,9000 | -356,3000 | -1.584,5000 | -711 | ||||||
| Veränderung der liquiden Mittel | 465 | 15,8000 | -332,8000 | -94,8000 | 375,4000 | ||||||
| Anzahl der Mitarbeiter | 13.900 | 14.900 | 15.700 | - | - | ||||||
